Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses-Reference-Cited by-同舟云学术

Recombinant Mycobacterium smegmatis with a pMyong2 vector expressing Human Immunodeficiency Virus Type I Gag can induce enhanced virus-specific immune responses

Published:2017-03-16 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Byoung-Jun,Gong Jeong-Ryeol,Kim Ga-Na,Kim Bo-Ram,Lee So-Young,Kook Yoon-Hoh,Kim Bum-Joon

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep44776.pdf

Reference51 articles.

1. Letvin, N. L. Strategies for an HIV vaccine. J Clin Invest 110, 15–20, doi: 10.1172/JCI15985 (2002).

2. Trunz, B. B., Fine, P. & Dye, C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367, 1173–1180, doi: 10.1016/S0140-6736(06)68507-3 (2006).

3. Lienhardt, C. & Zumla, A. BCG: the story continues. Lancet 366, 1414–1416, doi: 10.1016/S0140-6736(05)67535-6 (2005).

4. Roy, A. et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ 349, g4643, doi: 10.1136/bmj.g4643 (2014).

5. Baker, D. M., Nguyen-Van-Tam, J. S. & Smith, S. J. Protective efficacy of BCG vaccine against leprosy in southern Malawi. Epidemiol Infect 111, 21–25 (1993).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Boosting Immunogenicity of a Recombinant Mycobacterium smegmatis Strain via Zinc-Dependent Ribosomal Proteins;Biomedicines;2024-07-15

2. Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies;Frontiers in Immunology;2023-08-03

3. Mycobacterium smegmatis, a Promising Vaccine Vector for Preventing TB and Other Diseases: Vaccinomics Insights and Applications;Vaccines;2023-07-31

4. A recombinant Mycobacterium smegmatis -based surface display system for developing the T cell-based COVID-19 vaccine;Human Vaccines & Immunotherapeutics;2023-01-02

5. Experimental Evolution Reveals Redox State Modulates Mycobacterial Pathogenicity;Frontiers in Genetics;2022-03-16